USFDA Warning Letter to Akron Formulatio
The USFDA has issued a Warning Letter to Hyderabad-based OTC manufacturer Akron Formulations for critical
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
